WPD Pharmaceuticals (XCNQ:WBIO) Asset Impairment Charge : C$0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2008. Start your Free Trial

What is WPD Pharmaceuticals Asset Impairment Charge?

WPD Pharmaceuticals's Asset Impairment Charge for the three months ended in Sep. 2024 was C$0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.00 Mil.

WPD Pharmaceuticals Asset Impairment Charge Historical Data

The historical data trend for WPD Pharmaceuticals's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WPD Pharmaceuticals Asset Impairment Charge Chart

WPD Pharmaceuticals Annual Data

Trend

Jan13

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Dec20

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

0.03

WPD Pharmaceuticals Quarterly Data
	Jul19	Oct19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

WPD Pharmaceuticals Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

WPD Pharmaceuticals Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of WPD Pharmaceuticals's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

WPD Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (XCNQ:WBIO) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

8SV:Germany

Address

700-595 Burrard Street, Suite 401, Vancouver, BC, CAN, V7X 1S8

Website

https://www.wpdpharmaceuticals.com

WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, virology, research, and development of medicinal products involving biological compounds and small molecules.

Executives

Constantine Carmichel

Director

WPD Pharmaceuticals Headlines

No Headlines